论文信息 - Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420. - 字舞流文

Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.

W. Curran | Meihua Wang | M. Mehta | F. Lieberman | C. Tsien | Peixin Zhang | H. Robins | C. Schultz | A. Hartford | Ryan P. Smith | M. Werner-Wasik